Alcami Corporation
The Sr. Manager, Facilities and Maintenance at Alcami oversees maintenance programs and personnel for pharmaceutical facilities, process equipment, and critical utilities. The role ensures compliance with regulatory agency requirements like FDA, DEA, and EU while managing capital projects, plant shutdowns, and facility upgrades. This senior position involves leading a team of 5-8 direct reports and administering maintenance activities under strict GMP guidelines.
Headquarters
Wilmington, North Carolina, United States
Company Size
501-1000 employees
Founded
1979
Alcami is a contract development and manufacturing organization (CDMO) that provides end‑to‑end pharmaceutical development and manufacturing services for small molecules, biologics and sterile parenteral products. Its capabilities span analytical and formulation development, clinical and commercial manufacturing, sterile fill/finish, quality and regulatory support, and packaging to help biopharma companies advance therapies from early development to market. Alcami emphasizes compliance, robust quality systems, and flexible capacity to support complex programs and accelerated timelines. The company brands its customer-focused approach under the tagline “Beyond expectations.”
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alcami Corporation.
52% above the average for this role
Director: Engineering, Facilities and Validation
Emergent BioSolutions
Senior Analyst, QC Chemistry, US Site (Hopewell, NJ)
BeOne Medicines
Director of Facilities
AstraZeneca
Associate II, Quality Assurance, Document Control
Artiva Biotherapeutics
Senior Analyst, QC Chemistry, US Site (Hopewell, NJ)
BeOne Medicines
Head of Engineering
AstraZeneca